Research location
Chatham
Ontario, Canada
Advertisement
Research activity in Chatham
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 54 trials and 56 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Chatham
54 linked trials · page 1 of 2A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive DisorderNCT05593029 · 2022-11-09 · 1 site observation
COMPLETED
Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive DisorderNCT04830215 · 2021-04-01 · 1 site observation
COMPLETED
A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaNCT03893825 · 2019-04-17 · 1 site observation
COMPLETED
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneNCT03739203 · 2018-11-10 · 1 site observation
COMPLETED
Mindfulness Group-based Intervention for Early PsychosisNCT03143907 · 2018-02-22 · 1 site observation
COMPLETED
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 MonthsNCT03351244 · 2017-12-07 · 1 site observation
TERMINATED
Real-life Effectiveness of Vortioxetine in DepressionNCT03555136 · 2017-11-17 · 1 site observation
COMPLETED
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 YearNCT03230097 · 2017-09-29 · 1 site observation
TERMINATED
Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586 · 2017-01-01 · 1 site observation
TERMINATED
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)NCT02916056 · 2016-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)NCT02970305 · 2016-11-04 · 1 site observation
COMPLETED
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)NCT02970292 · 2016-10-26 · 1 site observation
COMPLETED
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in SchizophreniaNCT02832037 · 2016-07-25 · 1 site observation
COMPLETED
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseNCT02547818 · 2015-09-15 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderNCT02473289 · 2015-07-23 · 1 site observation
COMPLETED
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive DisorderNCT02466477 · 2015-06-01 · 1 site observation
COMPLETED
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseaseNCT02080364 · 2015-04-01 · 1 site observation
TERMINATED
Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking VortioxetineNCT02332954 · 2015-02-01 · 1 site observation
COMPLETED
Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025NCT02004392 · 2014-06-01 · 1 site observation
TERMINATED
Real Life Assessment of Abilify MaintenaNCT02131415 · 2014-05-01 · 1 site observation
TERMINATED
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsNCT01959529 · 2013-10-29 · 1 site observation
COMPLETED
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseNCT01969123 · 2013-10-01 · 1 site observation
TERMINATED
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation
COMPLETED
Cardiovascular Inflammation Reduction TrialNCT01594333 · 2013-04-01 · 1 site observation
COMPLETED
Consumer Access to Personal Health Information for Asthma Self-ManagementNCT01964469 · 2013-02-01 · 1 site observation
COMPLETED
Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On DonepezilNCT01712074 · 2012-11-01 · 2 site observations
TERMINATED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01 · 1 site observation
COMPLETED
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleNCT01509053 · 2012-01-01 · 1 site observation
TERMINATED
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01436149 · 2011-10-27 · 1 site observation
COMPLETED
COPE With COPD TrialNCT02343055 · 2011-10-01 · 1 site observation
COMPLETED
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)NCT01312922 · 2011-09-01 · 1 site observation
COMPLETED
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaNCT01397786 · 2011-09-01 · 1 site observation
COMPLETED
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleNCT01432444 · 2011-09-01 · 1 site observation
COMPLETED
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute SchizophreniaNCT01396421 · 2011-07-01 · 2 site observations
COMPLETED
Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionNCT01364649 · 2011-06-01 · 1 site observation
COMPLETED
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderNCT01377194 · 2011-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenNCT01165684 · 2010-10-01 · 1 site observation
COMPLETED
The Quietude Study: Quetiapine Use for Agitated DepressionNCT01363310 · 2010-10-01 · 1 site observation
TERMINATED
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionNCT01157364 · 2010-09-23 · 1 site observation
COMPLETED
Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive DisorderNCT01085812 · 2010-03-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinNCT01046110 · 2010-01-01 · 1 site observation
COMPLETED
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeNCT00748566 · 2008-12-01 · 1 site observation
TERMINATED
Quetiapine in Co-Morbid Depressive and Anxiety DisordersNCT00688818 · 2008-06-01 · 1 site observation
COMPLETED
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral AntipsychoticsNCT00696813 · 2008-06-01 · 1 site observation
COMPLETED
A Diabetes Study to Treat A Population Previously Not at TargetNCT00747149 · 2008-05-01 · 1 site observation
COMPLETED
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaNCT00640601 · 2008-03-01 · 1 site observation
COMPLETED
Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant AnxietyNCT00621270 · 2008-01-01 · 1 site observation
COMPLETED
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsNCT00396214 · 2007-04-01 · 1 site observation
TERMINATED
Switch Study of Existing Atypical Antipsychotics to BifeprunoxNCT00347425 · 2006-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.